Gene · 651
BMP3: bone morphogenetic protein 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. BMP3: bone morphogenetic protein 3. Genes, record 651. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/651
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P12645 | Bone morphogenetic protein 3 | 472 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents57
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| EP 4705273 A2 | 2026-03-11 | 514 | P12645 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 39065 | P12645 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 3177 | P12645 | Espacenet |
| EP 4640849 A2 | 2025-10-29 | 390 | P12645 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 2741 | P12645 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 1493 | P12645 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 5591 | P12645 | Espacenet |
| US 12371689 B2 | 2025-07-29 | 5591 | P12645 | Espacenet |
| JP 2025519096 A | 2025-06-24 | 390 | P12645 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 2741 | P12645 | Espacenet |
1 to 10 of 57
See all 57 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants799
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | BMP3 papers | Newest fiscal year |
|---|---|---|---|
| P30DK084567 | Mayo Center for Cell Signaling in Gastroenterology | 11 | 2025 |
| K12CA090628 | Paul Calabresi Program in Clinical/Translational Research at Mayo Clinic | 7 | 2025 |
| P30CA015083 | Mayo Clinic Comprehensive Cancer Center Support Grant | 6 | 2025 |
| P30CA015704 | Cancer Center Support Grant | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30CA014089 | University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG) | 3 | 2025 |
| UL1TR001863 | Yale Clinical and Translational Science Award | 3 | 2025 |
| P20GM103436 | IDeA Networks of Biomedical Research Excellence in Kentucky | 2 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 2 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 2 | 2025 |
1 to 10 of 799Source NIH's project files
See all 799 nih grantsPapers1,216
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Methylation biomarkers for early detection of colorectal cancer: From molecular discovery to clinical translation and application. | J Cancer Res Ther | 2026 | 42241155 | PubTator, text mining | PubMed |
| Genetic Risk Factors for Intracerebral Hemorrhage in Populations of East Asian Ancestry. | Neurol Genet | 2026 | 42146893 | PubTator, text mining | PubMed |
| An algorithm-enhanced stool DNA system improves the differential diagnosis of colorectal cancer versus Crohn's disease in high-risk symptomatic patients. | Comput Methods Programs Biomed | 2026 | 41950614 | PubTator, text mining | PubMed |
| MBD-Functionalized Magnetic Nanoparticles for Direct Enrichment of Plasma Methylated DNA in High-Sensitivity Liquid Biopsy. | Anal Chem | 2026 | 41922298 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapeutic strategies: DNA methylation in pancreatic cancer. | Cancer Biol Ther | 2026 | 41879036 | PubTator, text mining | PubMed |
| Epigenetic mechanisms and steroid-resistant nephrotic syndrome: The future potential for SRNS diagnosis. | iScience | 2026 | 41782821 | PubTator, text mining | PubMed |
| Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers. | J Gastroenterol Hepatol | 2026 | 41692706 | PubTator, text mining | PubMed |
| Multi-gene DNA methylation profiles of tumor suppressor genes for prognostic prediction in gastric cancer. | BMC Cancer | 2026 | 41634637 | PubTator, text mining | PubMed |
| Functional mechanism and clinical implications of lncRNA NNT-AS1 in delayed fracture healing. | Cytotechnology | 2026 | 41541237 | PubTator, text mining | PubMed |
| From bench to bedside: pancreatic juice as a platform for biomarker discovery in pancreatic disease. | Korean J Intern Med | 2026 | 41531214 | PubTator, text mining | PubMed |
1 to 10 of 1,216
See all 1,216 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/651
GET https://conductscience.org/api/genes/v1/651/patents?page=2